نتائج البحث - Lorelei J. Hanson

  • يعرض 1 - 3 نتائج من 3
تنقيح النتائج
  1. 1
    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer

    Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer حسب Alex A. Adjei, Julian R. Molina, Sumithra J. Mandrekar, Randolph S. Marks, Joel R. Reid, Gary A. Croghan, Lorelei J. Hanson, James R. Jett, Chenghua Xia, Chetan Lathia, Ronit Simantov

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

    Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies حسب Patricia LoRusso, Alex A. Adjei, Mary Varterasian, Shirish M. Gadgeel, Joel M. Reid, David Mitchell, Lorelei J. Hanson, Pamela DeLuca, Laura M. Bruzek, Jill Piens, Peggy Asbury, Keri Van Becelaere, Román Herrera, Judith S. Sebolt‐Leopold, Mark B. Meyer

    منشور في 2005
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

    Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced... حسب Alex A. Adjei, Roger B. Cohen, Wilbur A. Franklin, Clive Morris, David M. Wilson, Julian R. Molina, Lorelei J. Hanson, Lia Gore, Laura Q.M. Chow, Stephen Leong, Lara Maloney, Gilad S. Gordon, Heidi Simmons, Allison Marlow, Kevin Litwiler, Suzy Brown, G Pöch, Katie Kane, Jerry Haney, Sabine Eckhardt

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: